How would you approach a new pelvic mass in a patient with history of mixed germ cell tumor but normalized tumor markers?  

By the type of treatment received, I assume this was likely a post-pubescent male, probably under 18? In my view, this sort of patient should be managed identically to what we do in the much larger populations of non-seminoma seen between 18-40. Clinical and biological evidence is mounting that post...